SCHEMBL6011001

SCHEMBL6011001

N#Cc1ccc(/C=C/C2CCNCC2)cc1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MAOB P27338 7/20 0.57
▸ FBP1 P09467 1/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ LMNA P02545 1/20 0.41
▸ MAPT P10636 1/20 0.41
▸ L3MBTL1 Q9Y468 1/20 0.41
▸ SLC6A2 P23975 3/20 0.40
▸ SLC6A4 P31645 3/20 0.40
▸ SLC6A3 Q01959 2/20 0.40
▸ P4HB P07237 1/20 0.40
▸ HTR3A P46098 1/20 0.38
▸ KCNH2 Q12809 1/20 0.38
▸ KHK P50053 1/20 0.38
▸ HTT P42858 1/20 0.37
▸ SNCA P37840 1/20 0.36
▸ MAOA P21397 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL14783054 0.98 MAOB (0.56) MAOBFBP1ALDH1A1HDAC2LMNA
Hydrochloric Acid SCHEMBL14783053 0.98 MAOB (0.56) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL8454093 0.84 MAOB (0.58) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL9457910 0.81 MAOB (0.59) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL9457904 0.81 MAOB (0.59) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL29260529 0.81 MAOB (0.56) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL29260527 0.81 MAOB (0.56) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL24358835 0.79 MAOB (0.54) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL8450086 0.79 MAOB (0.53) MAOBFBP1ALDH1A1HDAC2LMNA
SCHEMBL15964288 0.79 MAOB (0.64) MAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018055096-A1 DISUBTITUTED AZETIDINES, PYRROLIDINES, PIPERIDINES AND AZEPANES AS INHIBITORS OF MONOAMINE OXIDASE B FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES UNIVERSITY OF LJUBLJANA (SI) 2018-03-29 — — WO disclosed
EP-1785415-B1 PIPERIDINE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF ASTELLAS PHARMA INC (JP) 2012-05-02 — — EP disclosed
Send feedback